ANTENGENE-B: (1) PROPOSALS FOR GENERAL MANDATES TO ISSUE AND RESELL SHARES AND TO REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE EIGHTH AMENDED AND RESTATED MEMORANDUM AND A
Apr 29 05:10 ET
ANTENGENE-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING
Apr 29 05:09 ET
ANTENGENE-B: NOTICE OF THE ANNUAL GENERAL MEETING
Apr 29 05:08 ET
ANTENGENE-B: Notification Letter to Registered Shareholders and Reply Form
Apr 29 05:06 ET
ANTENGENE-B: Notification Letter to Non-registered Holders and Reply Form
Apr 29 05:05 ET
ANTENGENE-B: 2023 ANNUAL REPORT
Apr 29 05:03 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 3 04:53 ET
ANTENGENE-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND CHANGE IN USE OF PROCEEDS
Mar 22 05:59 ET
ANTENGENE-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND CHANGE IN USE OF PROCEEDS
Mar 22 04:41 ET
ANTENGENE-B: NOTICE OF DATE OF BOARD MEETING
Mar 11 04:30 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 4 03:08 ET
ANTENGENE-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Feb 26 03:35 ET
ANTENGENE-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Feb 26 03:30 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 1 03:25 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 4 03:25 ET
ANTENGENE-B: VOLUNTARY ANNOUNCEMENT SELINEXOR (XPOVIO), ANTENGENE''S FIRST-IN-CLASS NEW DRUG, SUCCESSFULLY INCLUDED IN 2023 NATIONAL REIMBURSEMENT DRUG LIST
Dec 13, 2023 17:50 ET
ANTENGENE-B: VOLUNTARY ANNOUNCEMENT APPROVAL OF NDA BY THE PHARMACEUTICAL ADMINISTRATION BUREAU OF MACAU FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Dec 6, 2023 03:30 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 5, 2023 03:25 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Nov 3, 2023 04:25 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Oct 5, 2023 04:25 ET
No Data
No Data